Stock Market News
AstraZeneca beats Q2 profit and revenue estimates
2022.07.29 09:17
FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski/File Photo GLOBAL BUSINESS WEEK AHEAD
(Reuters) – AstraZeneca (NASDAQ:AZN) on Friday topped analyst expectations for second-quarter profit and revenue, helped by higher demand for its cancer medicines.
The London-listed company also raised its full-year revenue guidance, saying it expects it to rise by a percentage in the low twenties rather than the high teens forecast previously.